These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7095998)

  • 1. Immunological investigation and immunotherapy in patients operated on for breast carcinoma.
    Reynier J; Villet R; Bazin JC; Bizzini B; Gandrille C; Guettier C; Henocq E; Hollmann K; Mogenet M; Pompidou A; Santus JP; Verley JM
    Int Surg; 1982; 67(1):17-24. PubMed ID: 7095998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Carcinoma of the breast. Immune behaviour. Immunostimulation by fraction P40 (author's transl)].
    Reynier J; Bazin JC; Bizzini B; Gandrille C; Guettier C; Henocq E; Hollmann K; Mogenet M; Pompidou A; Santus JP; Verley JM; Villet R
    Chirurgie; 1980 Jan; 106(1):48-55. PubMed ID: 7379633
    [No Abstract]   [Full Text] [Related]  

  • 3. [Breast cancer: a dynamic approach of cellular immunity and immunostimulation with an immunoadjuvant: P40 fraction. (author's transl)].
    Santus JP; Henocq E; Bizzini B; Bazin JC; Mogenet M; Villet R; Reynier J
    Pathol Biol (Paris); 1979 Sep; 27(7):395-401. PubMed ID: 388318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological modifications following immunotherapy with P 40 in rats bearing DMBA-induced mammary carcinoma.
    Hollmann KH; Verley JM
    Experientia; 1980 Oct; 36(10):1213-5. PubMed ID: 6774883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
    North SM; Steck PA; Nicolson GL
    Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
    Kreider JW; Bartlett GL; Purnell DM; Webb S
    Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour models for screening immunomodulators: suppression of tumour growth by delayed hypersensitivity reactions.
    Pimm MV; Baldwin RW
    Behring Inst Mitt; 1984 May; (74):214-8. PubMed ID: 6383324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the antitumor effects of a synthetic biopolymer and standard adjuvants.
    Falk RE; Makowka L; Nossal NA; Rotstein LE; Falk JA
    Surgery; 1980 Jul; 88(1):126-36. PubMed ID: 6992317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of intratumoral immunostimulants in the treatment of a transplantable rat mammary carcinoma.
    Willmott N; Austin EB; Pimm MV; Baldwin RW
    Eur J Cancer (1965); 1981 Apr; 17(4):397-405. PubMed ID: 7308253
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunomodulation with P40, an insoluble delipidated fraction of Corynebacterium granulosum. II.--Specific immune responses of the host.
    Lagrange PH; Fuster MJ
    Ann Immunol (Paris); 1982; 133C(3):269-87. PubMed ID: 7149643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suitability of rat mammary adenocarcinoma 13762 as a model for BCG immunotherapy.
    Kreider JW; Bartlett GL; Purnell DM
    J Natl Cancer Inst; 1976 Apr; 56(4):797-802. PubMed ID: 815563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic adoptive transfer of immunity to 13762A rat mammary adenocarcinoma.
    Boyer CM; Kreider JW; Bartlett GL
    Cancer Res; 1981 Jun; 41(6):2394-400. PubMed ID: 6972251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An experimental and clinical study of immunocompetence and immunostimulation in breast cancer.
    Reynier J; Bazin JC; Bizzini B; Villet R; Chany C; Leandri S
    Int Surg; 1988; 73(1):10-5. PubMed ID: 3360570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune RNA in the immunotherapy of cancer.
    Pilch YH; Fritze D; Kern DH
    Med Clin North Am; 1976 May; 60(3):567-83. PubMed ID: 1271893
    [No Abstract]   [Full Text] [Related]  

  • 15. Rejection of tumors and metastases in Fischer 344 rats following intratumor administration of killed Corynebacterium parvum.
    Likhite VV
    Int J Cancer; 1974 Nov; 14(5):684-90. PubMed ID: 4459281
    [No Abstract]   [Full Text] [Related]  

  • 16. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG
    Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Destruction of regional lymph node metastases of rat mammary adenocarcinoma 13762A by treatment with Corynebacterium parvum.
    Kreider JW; Bartlett GL; Purnell DM; Webb S
    Cancer Res; 1978 Dec; 38(12):4522-6. PubMed ID: 719637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer-associated antigens by anti-idiotypic antibodies.
    Smorodinsky NI; Ghendler Y; Bakimer R; Chaitchuk S; Keydar I; Shoenfeld Y
    Eur J Immunol; 1988 Nov; 18(11):1713-8. PubMed ID: 2849550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
    Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonspecific Immunotherapy of Murine Solid Tumors With Corynebacterium granulosum.
    Milas L; Hunter B; Mason K; Grdina D; Withers H
    J Natl Cancer Inst; 1975 Apr; 54(4):895-902. PubMed ID: 1127718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.